Zum Hauptinhalt springen

Press Releases and Ad-hoc Announcements

04. Februar 2021
AH: FDA Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101
PDF
21. Dezember 2020
AH: Heidelberg Pharma AG Receives Shareholder Loan Based on an Existing Financing Commitment
PDF
12. November 2020
PR: Heidelberg Pharma will Present at German Equity Forum and Provides Update on Partner Activities for its Legacy Assets
PDF
05. November 2020
PR: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2020
PDF
08. Oktober 2020
PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020
PDF
29. September 2020
AH: Heidelberg Pharma AG Announces Adjustment of Guidance
PDF
14. September 2020
PR: Heidelberg Pharma Receives Milestone Payment from Partner Magenta
PDF
10. September 2020
PR: Heidelberg Pharma Announces Participation at Various Conferences
PDF
22. Juli 2020
PR: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions
PDF
21. Juli 2020
AH: Heidelberg Pharma AG: Main Shareholder dievini Commits to Further Financing for Expansion of Proprietary Pipeline
PDF